文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

法呢醇通过调节 2 型糖尿病大鼠 AMPK 介导的心脏脂质代谢通路减轻糖尿病心肌病。

Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats.

机构信息

Department of Critical Care Medicine, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, 437199, China.

Department of Neonatology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, 437199, China.

出版信息

Cell Biochem Biophys. 2024 Sep;82(3):2427-2437. doi: 10.1007/s12013-024-01353-2. Epub 2024 Jun 15.


DOI:10.1007/s12013-024-01353-2
PMID:38878100
Abstract

Diabetic cardiomyopathy (DCM) is a prevalent complication of diabetes mellitus characterized by cardiac dysfunction and myocardial remodeling. Farrerol (FA), an active ingredient in Rhododendron with various pharmacological activities, has an unclear specific role in DCM. Therefore, this study aims to investigate the effects of FA on DCM rats and elucidate its mechanism. The type 2 diabetes mellitus (T2DM) model was induced in adult male Sprague-Dawley rats by administering a high-fat diet for 8 weeks along with STZ injection. Subsequent to successful modeling, FA and the positive drug Dapagliflozin (Dapa) were orally administered via gavage for an additional 8-week period. After administration, the rats' body weight, fasting blood glucose, fasting insulin, and blood lipid profiles were quantified. Cardiac function was assessed through evaluation of cardiac function parameters, histopathological examination and measurement of myocardial enzyme markers were conducted to assess myocardial injury and fibrosis, Oil red O staining was utilized to evaluate myocardial lipid accumulation, wheat germ agglutinin (WGA) staining was used for assessing cardiomyocyte hypertrophy, and Western blot analysis was used to detect the proteins expression level of AMP-activated protein kinase (AMPK) pathway. The rat cardiomyocyte H9c2 were induced with palmitic acid to establish an in vitro cell model of myocardial lipid toxicity. Subsequently, the cells were subjected to treatment with FA and AMPK inhibitor Compound C, followed by assessment of lipid formation and expression levels of proteins related to the AMPK signaling pathway. The findings demonstrated that both FA and Dapa exhibited efficacy in ameliorating diabetic symptoms, cardiac dysfunction, myocardial fibrosis, cardiomyocyte hypertrophy, and lipid accumulation in T2DM rats. Additionally, they were found to enhance AMPK phosphorylation and PPARα expression while down-regulating CD36. Similarly, FA was observed to inhibit lipid formation in H9c2 and activate the AMPK signaling pathway. However, the improved effect of FA on lipotoxic cardiomyocytes induced by palmitic acid was partially reversed by Compound C. Therefore, the activation of the AMPK signaling pathway by FA may enhance cardiac lipid metabolism, thereby improving cardiac dysfunction and myocardial fibrosis in DCM rats.

摘要

糖尿病心肌病(DCM)是糖尿病的一种常见并发症,其特征为心脏功能障碍和心肌重构。法呢醇(FA)是一种具有多种药理活性的杜鹃花中的活性成分,其在 DCM 中的具体作用尚不清楚。因此,本研究旨在探讨 FA 对 DCM 大鼠的作用及其机制。通过给予高脂肪饮食 8 周并注射 STZ,诱导成年雄性 Sprague-Dawley 大鼠 2 型糖尿病(T2DM)模型。成功建模后,通过灌胃给予 FA 和阳性药物达格列净(Dapa),再进行 8 周的治疗。给药后,检测大鼠体重、空腹血糖、空腹胰岛素和血脂谱。通过评估心功能参数来评估心功能,进行组织病理学检查和心肌酶标志物测量来评估心肌损伤和纤维化,油红 O 染色评估心肌脂质堆积,小麦胚凝集素(WGA)染色评估心肌细胞肥大,Western blot 分析检测 AMP 激活蛋白激酶(AMPK)通路蛋白的表达水平。用棕榈酸诱导大鼠心肌细胞 H9c2 建立心肌脂质毒性的体外细胞模型。然后,用 FA 和 AMPK 抑制剂 Compound C 处理细胞,评估脂质形成和 AMPK 信号通路相关蛋白的表达水平。结果表明,FA 和 Dapa 均能改善 T2DM 大鼠的糖尿病症状、心功能障碍、心肌纤维化、心肌细胞肥大和脂质堆积。此外,它们还能增强 AMPK 磷酸化和 PPARα 表达,同时下调 CD36。同样,FA 能抑制 H9c2 中的脂质形成并激活 AMPK 信号通路。然而,Compound C 部分逆转了 FA 对棕榈酸诱导的脂毒性心肌细胞的改善作用。因此,FA 通过激活 AMPK 信号通路增强心脏脂质代谢,从而改善 DCM 大鼠的心功能障碍和心肌纤维化。

相似文献

[1]
Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats.

Cell Biochem Biophys. 2024-9

[2]
Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-B.

Comput Math Methods Med. 2022

[3]
Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.

J Cell Mol Med. 2021-8

[4]
Effect of extracellular matrix stiffness on efficacy of Dapagliflozin for diabetic cardiomyopathy.

Cardiovasc Diabetol. 2024-7-24

[5]
Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.

Cell Death Dis. 2018-2-14

[6]
Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT/JAK/MAPK pathways in streptozotocin-induced diabetic rats.

Chem Biol Interact. 2021-9-25

[7]
Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.

Cell Physiol Biochem. 2018

[8]
The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification.

Biomed Pharmacother. 2024-8

[9]
Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.

Cardiovasc Drugs Ther. 2020-8

[10]
Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function.

Toxicol Appl Pharmacol. 2021-6-15

引用本文的文献

[1]
Identification of lipid metabolism-related genes in dapagliflozin treated rats with diabetic cardiomyopathy by bioinformatics.

Front Endocrinol (Lausanne). 2025-3-20

本文引用的文献

[1]
Identification and Potential Clinical Utility of Common Genetic Variants in Gestational Diabetes among Chinese Pregnant Women.

Diabetes Metab J. 2025-1

[2]
ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis.

J Transl Med. 2024-2-23

[3]
Integrated mass spectrometry imaging reveals spatial-metabolic alteration in diabetic cardiomyopathy and the intervention effects of ferulic acid.

J Pharm Anal. 2023-12

[4]
Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells.

Front Pharmacol. 2023-12-5

[5]
CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease.

Physiol Rev. 2024-4-1

[6]
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice.

Biomed Pharmacother. 2023-8

[7]
Farrerol prevents Angiotensin II-induced cardiac remodeling and .

Front Pharmacol. 2023-1-4

[8]
A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.

Am J Physiol Heart Circ Physiol. 2023-2-1

[9]
Diabetic cardiomyopathy: Clinical phenotype and practice.

Front Endocrinol (Lausanne). 2022

[10]
Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu.

J Clin Med. 2022-11-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索